[go: up one dir, main page]

CY1106010T1 - Παροχη φαρμακου σχηματισμου μεταβαλλομενης φασης - Google Patents

Παροχη φαρμακου σχηματισμου μεταβαλλομενης φασης

Info

Publication number
CY1106010T1
CY1106010T1 CY20071100186T CY071100186T CY1106010T1 CY 1106010 T1 CY1106010 T1 CY 1106010T1 CY 20071100186 T CY20071100186 T CY 20071100186T CY 071100186 T CY071100186 T CY 071100186T CY 1106010 T1 CY1106010 T1 CY 1106010T1
Authority
CY
Cyprus
Prior art keywords
drug
formulation
body surface
solid phase
human body
Prior art date
Application number
CY20071100186T
Other languages
English (en)
Inventor
Jie Zhang
Original Assignee
Zars, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zars, Inc. filed Critical Zars, Inc.
Publication of CY1106010T1 publication Critical patent/CY1106010T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται σε μία συσκευή και μέθοδο παροχής φαρμάκου σε μια επιφάνεια ανθρώπινου σώματος. Ο σχηματισμός περιλαμβάνει ένα φάρμακο, ένα παράγοντα μετατροπής ικανό μετατροπής του σχηματισμού από μια λιγότερο στερεή φάση σε μια με συνοχή, μαλακή, στερεή φάση, και ένα μέσο οχήματος ή φορέα για το φάρμακο και τον παράγοντα μετατροπής. Ο σχηματισμός φαρμάκου εφαρμόζεται σ' αυτήν την επιφάνεια ανθρώπινου σώματος στην λιγότερο από στερεή φάση του και μετατρέπεται στη συνέχεια σε μια μαλακή στερεή φάση ενώ το φάρμακο παρέχεται διαμέσου της επιφάνειας ανθρώπινου σώματος. Αφού περατωθεί η παροχή του φαρμάκου, ο μαλακός στερεός σχηματισμός μπορεί να απομακρυνθεί ή να ξεφλουδιστεί από την επιφάνεια σώματος ως ένας με συνοχή στερεός σχηματισμός. Ο σχηματισμός φαρμάκου παρέχει έλεγχο επάνω στους ρυθμούς παροχής φαρμάκου και επιτρέπει την απομάκρυνση του σχηματισμού χωρίς να αφήνεται ένας ρυπαρός, υπολειμματικός σχηματισμός επάνω στην επιφάνεια του σώματος.
CY20071100186T 1999-09-28 2007-02-12 Παροχη φαρμακου σχηματισμου μεταβαλλομενης φασης CY1106010T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/407,720 US6528086B2 (en) 1999-09-28 1999-09-28 Methods and apparatus for drug delivery involving phase changing formulations
PCT/US2000/026478 WO2001022907A1 (en) 1999-09-28 2000-09-27 Drug delivery of phase changing formulation

Publications (1)

Publication Number Publication Date
CY1106010T1 true CY1106010T1 (el) 2011-04-06

Family

ID=23613253

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100186T CY1106010T1 (el) 1999-09-28 2007-02-12 Παροχη φαρμακου σχηματισμου μεταβαλλομενης φασης

Country Status (13)

Country Link
US (1) US6528086B2 (el)
EP (2) EP1702597A3 (el)
JP (4) JP2003510259A (el)
CN (2) CN101219108A (el)
AT (1) ATE345757T1 (el)
AU (1) AU7719800A (el)
CA (1) CA2386017C (el)
CY (1) CY1106010T1 (el)
DE (1) DE60032021T2 (el)
DK (1) DK1244401T3 (el)
ES (1) ES2276697T3 (el)
PT (1) PT1244401E (el)
WO (1) WO2001022907A1 (el)

Families Citing this family (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020114827A1 (en) * 1995-07-28 2002-08-22 Jie Zhang Methods and apparatus for improved administration of analgesics
US20040265353A1 (en) * 1995-07-28 2004-12-30 Zars, Inc. Systems and methods for treating panic attacks
IL144679A0 (en) * 1999-02-03 2002-06-30 Teva Pharma Process for the preparation of pseudomonic acid a antibiotic by microbiological method
AU5286901A (en) * 1999-10-22 2001-06-18 Transdermatech, Inc. Topical anesthetic formulation
US10179159B2 (en) 1999-10-22 2019-01-15 Scott Wepfer Topical anesthetic formulation
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
MXPA03012044A (es) * 2001-06-21 2004-06-17 Biogal Gyogyszergyar Proceso de fermentacion controlado metabolico para la produccion de acido pseudomonico.
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
KR20040075857A (ko) * 2001-12-28 2004-08-30 비오갈 기오기스제르갸르 알티. 결정질 및 비결정질 무피로신 칼슘의 제조 방법
CN1272071C (zh) 2002-03-14 2006-08-30 美德阿利克斯株式会社 创伤用外用剂
WO2003092704A1 (fr) * 2002-04-30 2003-11-13 Mochida Pharmaceutical Co., Ltd. Preparation externe de vidarabine a propriete systemique amelioree
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
KR20050083605A (ko) * 2002-07-31 2005-08-26 알자 코포레이션 주사 가능한 다원성 중합체 데포트 조성물 및 이의 용도
JP2006503004A (ja) * 2002-07-31 2006-01-26 アルザ・コーポレーション 射出可能なデポ組成物及びその使用
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
NZ540166A (en) * 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
KR20050109562A (ko) * 2003-03-13 2005-11-21 쓰리엠 이노베이티브 프로퍼티즈 컴파니 피부의 질을 개선시키는 방법
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
CA2534372C (en) * 2003-08-04 2012-01-24 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
MXPA06002163A (es) * 2003-08-25 2006-05-22 Foamix Ltd Espuma farmaceutica de penetracion.
JP2005310310A (ja) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd トラッキングバランス調整装置
US20050255150A1 (en) * 2004-04-26 2005-11-17 Cassel Douglas R Wound treatment patch for alleviating pain
GB0410839D0 (en) * 2004-05-14 2004-06-16 Glaxo Group Ltd Novel device
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
CA2560984A1 (en) * 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US20060105028A1 (en) * 2004-11-12 2006-05-18 Jie Zhang Systems and methods for treating warts
US20060105029A1 (en) * 2004-11-12 2006-05-18 Jie Zhang Instant patch for dermal drug delivery
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2006096914A1 (en) 2005-03-15 2006-09-21 Animal Ethics Pty Ltd A topical analgesic composition
US7338673B2 (en) * 2005-05-05 2008-03-04 Ferrell Jr Thomas H Medicated patch for treating bee and wasp stings
AU2006326388B2 (en) * 2005-12-14 2013-01-24 Nuvo Research Inc. Compositions and methods for treating dermatological conditions
JP2009524586A (ja) * 2005-12-14 2009-07-02 ザーズ, インコーポレイテッド 疼痛を皮膚処置するための組成物および方法
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
WO2008011161A2 (en) * 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds
WO2008023237A2 (en) * 2006-08-23 2008-02-28 Martin Wenckens Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)
CN101563058A (zh) * 2006-09-08 2009-10-21 弗米克斯有限公司 有色的或可着色的能起泡的组合物和泡沫
MX2009003022A (es) * 2006-09-21 2009-06-01 Coastal Solutions Inc Composiciones y metodos para tratar picaduras de medusa.
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080146672A1 (en) * 2006-12-08 2008-06-19 Denton Marcia Marye Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
CA2675797A1 (en) * 2007-01-16 2008-07-24 Dermworx, Incorporated Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
WO2008097646A1 (en) 2007-02-09 2008-08-14 Schering Corporation Methods to treat and/or prevent mucositis
EP2136863A2 (en) * 2007-03-19 2009-12-30 Insuline Medical Ltd. Device for drug delivery and associated connections thereto
US9220837B2 (en) * 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8622991B2 (en) * 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
CN104069567A (zh) * 2007-03-19 2014-10-01 茵苏莱恩医药有限公司 药物输送设备
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
JP5965147B2 (ja) * 2008-05-26 2016-08-03 ノバルティス アーゲー 薬剤の局所適用のためのキット
ES2759373T3 (es) 2008-06-12 2020-05-08 Medtronic Xomed Inc Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
CN102112112A (zh) * 2008-07-21 2011-06-29 奥德纳米有限公司 用于治疗耳部病症的受控释放抗微生物组合物和方法
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
MX2011003510A (es) 2008-10-02 2011-06-17 Mylan Inc Metodo para fabricar un laminado adhesivo de multiples capas.
US8961458B2 (en) 2008-11-07 2015-02-24 Insuline Medical Ltd. Device and method for drug delivery
US9012477B2 (en) * 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US20110086913A1 (en) * 2009-04-01 2011-04-14 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
WO2010129542A1 (en) * 2009-05-04 2010-11-11 Jie Zhang Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
EP2523660A4 (en) 2010-01-14 2013-07-10 Nuvo Res Inc FORMATION OF SOLID FORMS OF LOCAL ANESTHESIA FORMULATIONS FOR FIGHTING PAIN
EP2547323B1 (en) 2010-03-17 2016-01-27 Novaliq GmbH Pharmaceutical composition for treatment of increased intraocular pressure
KR101792200B1 (ko) 2010-04-01 2017-10-31 파마네스트 아베 열감응성 겔 마취제 조성물
WO2011133177A1 (en) 2010-04-21 2011-10-27 Teikoku Pharma Usa, Inc. Local anesthetic emulsion compositions and methods of making and using the same
US20130184678A1 (en) * 2010-10-11 2013-07-18 King Saud University Dual action syringe
WO2012106739A1 (de) 2011-02-11 2012-08-16 Helmut Buchberger Inhalatorkomponente
ES2743524T3 (es) 2011-05-10 2020-02-19 Itochu Chemical Frontier Corp Parche no acuoso
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
PT2714010T (pt) * 2011-05-25 2017-05-05 Novaliq Gmbh Composição farmacêutica tópica à base de alcanos semifluorados
MX352752B (es) 2011-09-27 2017-12-06 Itochu Chemical Frontier Corp Parche no acuoso.
KR20130004213U (ko) * 2011-12-29 2013-07-09 오스템임플란트 주식회사 젤의 도포를 위한 주사기 분출부 체결용 팁
DE202013012742U1 (de) 2012-09-12 2019-01-22 Novaliq Gmbh Zusammensetzungen umfassend Mischungen aus semifluorierten Alkanen
EP3488847B1 (en) 2012-09-12 2023-11-08 Novaliq GmbH Semifluorinated alkane compositions
WO2014123100A1 (ja) * 2013-02-05 2014-08-14 リンテック株式会社 貼付型表面麻酔剤
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
CA2936247A1 (en) 2014-01-22 2015-07-30 Marcio Marc Abreu Devices and methods for transdermal drug delivery
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
PT3355990T (pt) 2015-09-30 2019-09-11 Novaliq Gmbh Compostos semifluorados e as suas composições
PT3356313T (pt) 2015-09-30 2020-07-13 Novaliq Gmbh 2-perfluoro-hexiloctano para administração oftálmica
PL3442480T3 (pl) 2016-06-23 2020-04-30 Novaliq Gmbh Sposób podawania miejscowego
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2018055101A1 (en) 2016-09-23 2018-03-29 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
ES2957559T3 (es) 2017-04-21 2024-01-22 Dermaliq Therapeutics Inc Composiciones de yodo
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
IL273531B2 (en) 2017-09-27 2024-05-01 Novaliq Gmbh Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
GB2568920A (en) * 2017-11-30 2019-06-05 Jenarron Therapeutics Ltd Stable wound care formulation
CN110038130A (zh) * 2018-01-17 2019-07-23 张洁 药物组合物、贴剂及其制备方法、应用
KR101922372B1 (ko) * 2018-02-14 2019-02-13 문형주 확장형 개구를 포함하는 치과용 노즐팁
MX2020009132A (es) 2018-03-02 2020-12-11 Novaliq Gmbh Composiciones farmaceuticas que comprenden nebivolol.
JP2021522219A (ja) 2018-04-27 2021-08-30 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
US11510855B2 (en) 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
BR112021005350A8 (pt) 2018-09-27 2023-03-21 Novaliq Gmbh Reparo de barreira lipídica
CA3112031A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
CN111821257A (zh) * 2019-04-15 2020-10-27 湖州依诺唯新药物制剂有限公司 药物制剂、含其的系统及其制备方法、应用
JP7581349B2 (ja) * 2019-10-24 2024-11-12 ジャニーン ホプキンス アプリケータデバイスおよびキット
CZ308630B6 (cs) 2019-11-23 2021-01-13 Grade Medical s.r.o. Zařízení pro přípravu funkcionalizovaných substrátů
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CA3168712A1 (en) * 2020-02-25 2021-09-02 The University Of North Carolina At Chapel Hill Eutectic based anesthetic compositions and applications thereof
CN113230527B (zh) * 2021-05-15 2023-06-02 宋伟 一种胸外科用辅助上药装置
WO2024146576A1 (zh) * 2023-01-04 2024-07-11 新领医药技术(深圳)有限公司 利培酮透皮施用系统及其制备方法和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5279018A (en) * 1975-12-24 1977-07-02 Kuraray Co Ltd Analgesic embrocation
GB2004746B (en) * 1977-10-03 1982-03-10 Scherico Ltd Stable hopical anaesthetic compositions
SE7713617L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Antitranspirationsmedel
JPS6089416A (ja) * 1983-10-24 1985-05-20 Terumo Corp 外用基剤組成物
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPS6267017A (ja) * 1985-09-19 1987-03-26 Sanwa Kagaku Kenkyusho:Kk 被膜形成型揮散性薬物含有軟膏剤
JPS62263120A (ja) * 1986-05-09 1987-11-16 Sekisui Chem Co Ltd 貼付剤
JP2635338B2 (ja) * 1987-10-22 1997-07-30 帝國製薬株式会社 保護膜形成型製剤
EP0386960A3 (en) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
EP0569532A1 (en) * 1991-02-01 1993-11-18 Stiefel Laboratories, Inc. Improved flexible collodion compositions
JP3549540B2 (ja) * 1994-03-30 2004-08-04 アルザ・コーポレーション 電気的移送式投与中の皮膚刺激状態の軽減
US5658583A (en) * 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5906814A (en) * 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
PT957906E (pt) * 1996-10-14 2002-07-31 Kowa Co Anestesico local para uso externo
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
SE9704031D0 (sv) * 1997-11-05 1997-11-05 Astra Ab Novel formulation
US6036966A (en) * 1998-02-17 2000-03-14 Youssefyeh; Rena T. Skin treatment compositions comprising protein and enzyme extracts

Also Published As

Publication number Publication date
JP2003510259A (ja) 2003-03-18
EP1702597A3 (en) 2008-03-26
CA2386017A1 (en) 2001-04-05
US20020004063A1 (en) 2002-01-10
ATE345757T1 (de) 2006-12-15
JP2007126462A (ja) 2007-05-24
CA2386017C (en) 2010-04-06
US6528086B2 (en) 2003-03-04
PT1244401E (pt) 2007-02-28
EP1244401B1 (en) 2006-11-22
ES2276697T3 (es) 2007-07-01
CN100367927C (zh) 2008-02-13
CN1376043A (zh) 2002-10-23
JP2007217431A (ja) 2007-08-30
JP2012246315A (ja) 2012-12-13
WO2001022907A1 (en) 2001-04-05
AU7719800A (en) 2001-04-30
EP1244401A4 (en) 2004-08-11
EP1702597A2 (en) 2006-09-20
DE60032021D1 (de) 2007-01-04
DE60032021T2 (de) 2007-06-14
EP1244401A1 (en) 2002-10-02
DK1244401T3 (da) 2007-02-19
CN101219108A (zh) 2008-07-16

Similar Documents

Publication Publication Date Title
CY1106010T1 (el) Παροχη φαρμακου σχηματισμου μεταβαλλομενης φασης
ATE369150T1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
PT840621E (pt) Adesivos com hormonas
WO2004112651A3 (en) Chordae tendinae girdle
HUP0103883A2 (hu) Új, késleltetett felszabadulású, orális készítmények
AU4684500A (en) Method and apparatus for adjustable sling for treatment of urinary stress incontinence
DE60325839D1 (de) Mit 40-o-(2-hydroxy)ethyl-rapamycin beschichteter stent
DK230188D0 (da) Grundlag for slimhinde- og proteseklaebepastaer samt fremstilling og anvendelse heraf
NZ513472A (en) Apparatus for treating fractured or diseased bone using plastically expandable bodies
NL300307I1 (nl) Werkwijzen voor de replicatie van influenzavirussen in celkweek en de influenzavirussen die verkrijgbaar zijn met behulp van de werkwijze
IL137712A0 (en) Light-activated tooth whitening composition and method of using same
HUP0001748A2 (hu) Transzdermális eszköz tesztoszteron felszabadítására
DE69415969D1 (de) Ungesättigtes nitril/konjugiertes dien-copolymer, verfahren zu dessen herstellung sowie kautschukzusammensetzung
EP1048325A3 (en) Manifold device for manipulation of radioactive fluid
MXPA01009316A (es) Metodo para exrpesar una molecula antigenica, o una parte de la misma, sobre la superficie de una celula por incorporacion fotoquimica.
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
ATE429880T1 (de) Vorrichtung zur prävention von bruxismus
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
AU3278099A (en) Device and method for applying a medium to a substrate, system having a plurality of such devices, and use of such device, method and system
ATE135359T1 (de) Sulfoniumsalze und verfahren zu deren herstellung
HUT77631A (hu) Eljárás a levobupivakain és származékai rezolválására
HUP0104728A2 (hu) Átlátszó transzdermális nikotinadagoló eszköz
EP1084683A3 (de) Verfahren und Vorrichtung zur Begrenzung des Drehmomentes zahnärztlicher und chirurgischer Handstücke
IL140475A0 (en) A device and method for the treatment of erectile dysfunction
AU2002217668A1 (en) Activity aid apparatus